Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: 2018 Biopharma VC Investment Could Beat 2017 One Quarter Ahead Of Schedule

Executive Summary

With biopharma venture capital investment of $9.67bn during the first half, 2018's total is on track to beat 2017 in the third quarter. IPOs, one of the factors fueling VC investment, continue to boom with five more drug developers slated to go public this week.

Advertisement

Related Content

Wellcome Trust Seeks 'Talent Scout' CEO For New Fund For Risky Health Ideas
Forbion Sees First Close Of New Biotech Fund At €270M In Record Time
Roivant Cuts Jobs, Reallocates Staff As It Prepares To Put New Stars In The Spotlight
Finance Watch: Early-Stage Firms Gain Deal-Making Insight As Golumbeski Joins VC Ranks
Modus CEO Says Rare Disease Priority Review Voucher To Be Key Catalyst
Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend
Venture Funding Deals: From ADC To Y-mAbs, Capital Flows For New Platforms, Novel Approaches
What's Next For Roivant? It's Not More Publicly Traded "Vants"
Deal Watch: Merck KGAA, Pfizer, eFFECTOR Agree To PD-L1/MNK Combo Study In CRC
Another Early-Stage VC Win: Pliant Raises $45m For Fibrosis Startup

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123423

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel